#MedicalScientists say single dose of compound developed at #Ben-GurionUniversity could speed up #eggmaturation and #ovulation By SHOSHANNA SOLOMON #Israeliresearchers say they may have found a new compound that can help #boostfertility…
May 01, 2018 - RESEARCH Inspired by tiny structures on transparent #butterflywings, scientists have developed a light-#manipulatingsurface for more effective and longer-lasting #eyeimplants for #glaucoma patients. Sections of the…
MALVERN, Pa.|May 2, 2018 #DSG, Inc., an industry leader in #eClinicalsoftware and services to the life sciences industry will be exhibiting at the 17th #MIXiii-#BIOMED2018 Conference and Exhibition. The conference…
NovellusDx CEO: The funds will let us move into commercialization and enable us to meet the need for functional oncology worldwide. #Israeli #functionalgenomics and #cancer profiling company #NovellusDx today…
Tova Cohen | Reuters Biologists work in a laboratory at Pluristem Therapeutics in Haifa. A laboratory worker removes cells from a storage unit at Pluristem Therapeutics in Haifa, Israel March…
by Nick Paul Taylor | FierceBiotech | Apr 30, 2018 SteadyMed's pump technology. (SteadyMed) United #Therapeutics has struck a $216 million deal to buy #SteadyMed. The acquisition enables United to eliminate a potential threat…
Scientists at Bath University have developed a wearable sensor that measures glucose levels through the skin, an advance that could mark the end of finger-prick blood tests for diabetics.…
Dear Partners, MIXiii-BIOMED Israel 2018 promises to follow the tradition of successful events.This year’s program will consist of 9 tracks, each of them will host plenary and keynote speakers, a panel discussion and…
V-Wave develops a minimally #invasive #implanted #shuntdevice for treating patients with severe #heartfailure Meir Orbach | 26.04.18 | CTech Israeli #medical shunt #developer V-Wave Ltd. announced on Thursday it completed a $70…
News| Globes The company is developing a drug for treatment of cystic fibrosis. Eloxx Pharmaceuticals, which develops drugs for rare genetic diseases, announced that it has raised $50 million at…